Silence Therapeutics Got 130% Over Market. Now Institutions Are Pricing the Next RNA Bid.
Merck KGaA’s $1.3 billion all-cash deal arrived days after Beijing moved to curb foreign takeovers of Chinese siRNA platforms.
Merck KGaA’s $1.3 billion all-cash deal arrived days after Beijing moved to curb foreign takeovers of Chinese siRNA platforms.
October 20, 2026 With output down 19% and cash copper at $14,822 a tonne, investors face a choice the quarterly…
October 20, 2026 Bonus Content: Silence Therapeutics Got 130% Over Market. Now Institutions Are Pricing the Next RNA Bid. A…
October 20, 2026 Bonus Content: Samsung and SK Hynix Are Losing Their Grip on Memory Pricing A note from our…
Microsoft quit a U.K. data center over grid delays, but it just locked in 20 years of Indiana power. The real compounders may sit behind the meter.
The question portfolio managers were already asking quietly is now loud. Microsoft has terminated its anchor tenant agreement at Nscale’s…
The OAT-Bund spread, French bank stocks, and a Moody’s review on Friday tell a clearer story than burning city halls.
A note from our friends at Crypto 101(ad) Dear Investor, The Trump memecoin is running another contest. Hold enough of…
October 19, 2026 Bonus Content: The CSI 300 Has a Buyer. That Is Not the Same as a Bottom. A…
FAA approval could still land this week, unlocking nearly 1,500 backlog orders and turning stored jets into 2027 delivery revenue.